CO

Global Cord Bloo
NYSE

Real-time Quotes | Nasdaq Last Sale

2.680
-0.010
-0.37%
Closed 15:59 05/18 EDT
OPEN
2.690
PREV CLOSE
2.690
HIGH
2.700
LOW
2.600
VOLUME
88.60K
TURNOVER
59.78K
52 WEEK HIGH
6.31
52 WEEK LOW
2.100
MARKET CAP
325.76M
P/E (TTM)
3.952
1D
5D
1M
3M
1Y
5Y
5 Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be...
Benzinga · 2d ago
BRIEF-Blue Ocean Structure Investment Says Grand Court Of Cayman Islands Granted Injunction Order To Stop Global Cord Blood's Planned Acquisition Of Cellenkos
reuters.com · 5d ago
Global Cord Blood Shareholder Blue Ocean Issues Release Highlighting Successful Applied Injunction To Stop Co. From Acquiring Cellenkos Following Cayman Islands Court Ruling
Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant shareholder of Global Cord Blood Corporation (the "Company" or "Global Cord") (NYSE:CO), today announced that the
Benzinga · 5d ago
BRIEF-Global Cord Blood Announces Receipt Of Blue Ocean Petition
reuters.com · 05/10 21:41
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the Company has received a cop...
PR Newswire · 05/10 20:16
BRIEF-Blue Ocean Urges Shareholders Of Global Cord Blood Corporation To Join Forces To Terminate Its Proposed Acquisition Of Cellenkos Inc
reuters.com · 05/09 16:16
92 Biggest Movers From Friday
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services.
Benzinga · 05/09 10:27
66 Biggest Movers From Yesterday
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday.
Benzinga · 05/03 10:08
More
No Data
Learn about the latest financial forecast of CO. Analyze the recent business situations of Global Cord Bloo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average CO stock price target is 15.00 with a high estimate of 15.00 and a low estimate of 15.00.
High15.00
Average15.00
Low15.00
Current 2.680
EPS
Actual
Estimate
0.040.090.130.17
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Institutional Holdings
Institutions: 51
Institutional Holdings: 26.41M
% Owned: 21.73%
Shares Outstanding: 121.55M
TypeInstitutionsShares
Increased
9
864.73K
New
7
252.53K
Decreased
7
303.05K
Sold Out
7
251.57K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-4.48%
Healthcare Providers & Services
-4.31%
Key Executives
Chairman/Chief Executive Officer/Director
Ting Zheng
Chief Financial Officer/Director
Albert Chen
Corporate Executive
Rui Arashiyama
Chief Technology Officer
Xin Xu
Non-Executive Director
Ping Xu
Non-Executive Independent Director
Mark Chen
Non-Executive Independent Director
Siu Chuen Cheng
Non-Executive Independent Director
Jack Chow
Non-Executive Independent Director
Ken Lu
Non-Executive Independent Director
Jennifer Weng
No Data
No Data
About CO
Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Webull offers kinds of Global Cord Blood Corp stock information, including NYSE:CO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CO stock methods without spending real money on the virtual paper trading platform.